Comment on

• Visual Acuity Outcome over Time in Non-Infectious Uveitis.

  Pistilli M, Joffe MM, Gangaputra SS, Pujari SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Begum H, Fitzgerald TD, Dreger KA, Altaweel MM, Holbrook JT, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group. Pistilli M, et al. Ocul Immunol Inflamm. 2021 Aug 18;29(6):1064-1071. doi: 10.1080/09273948.2019.1687733. Epub 2019 Dec 10. Ocul Immunol Inflamm. 2021. PMID: 31821051 Free PMC article.
• Incidence and Risk Factors for Blindness in Uveitis: A Nationwide Cohort Study from 2002 to 2013.

  Oh BL, Lee JS, Lee EY, Lee HY, Yu HG. Oh BL, et al. Ocul Immunol Inflamm. 2021 Aug 18;29(6):1040-1044. doi: 10.1080/09273948.2020.1746352. Epub 2020 Apr 15. Ocul Immunol Inflamm. 2021. PMID: 32293927
• Economic Hardship, Ocular Complications, and Poor Self-reported Visual Function are Predictors of Mental Problems in Patients with Uveitis.

  Jin Y, Lin D, Dai ML, Liu R, Jiang M, Zheng J, Yang YM, Zhu XF, Wang YL, Huang XF, Wang Y. Jin Y, et al. Ocul Immunol Inflamm. 2021 Aug 18;29(6):1045-1055. doi: 10.1080/09273948.2020.1770297. Epub 2020 Jul 13. Ocul Immunol Inflamm. 2021. PMID: 32657648
• Contemporaneous Risk Factors for Visual Acuity in Non-Infectious Uveitis.

  Pistilli M, Gangaputra SS, Pujari SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Begum H, Fitzgerald TD, Dreger KA, Kempen JH. Pistilli M, et al. Ocul Immunol Inflamm. 2021 Aug 18;29(6):1056-1063. doi: 10.1080/09273948.2020.1828493. Epub 2021 Feb 23. Ocul Immunol Inflamm. 2021. PMID: 33621148